The global virtual clinical trials marketsize is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.
There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology.
The market is recovering at a significant pace after the pandemic as it offers various benefits to patients as well as sponsors. During the pandemic, traveling was potentially dangerous. It can be expensive, even incurring lost wages or requiring that childcare/eldercare be hired. These drawbacks limit initial interest and provide a simple solution for virtual clinical trials. Virtual clinical trials offer various benefits such as effective data collection, analysis, and monitoring large amounts of data in real-time.
Virtual trials make use of monitoring devices, software apps, online social engagement platforms to conduct every step of the clinical trial process including patient recruitment, counseling, measuring clinical endpoints, informed consent, and adverse reactions. Telehealth, home care, and remote patient monitoring has been gaining momentum as a healthcare offering, and the COVID-19 is adding more horsepower to this initiative.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/virtual-clinical-trials-market
Virtual Clinical Trials Market Report Highlights
• The oncology segment held 25.2% of the revenue share in 2021. The increasing adoption of virtual trials especially in oncology clinical research for the diverse populations is responsible for the growth of the segment
• The interventional design segment accounted for the largest revenue share of 46.7% in 2021
• North America held 49.2% of the revenue share in 2021. Favorable government initiatives and the presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth.
• In Asia Pacific, the market is expected to witness the fastest CAGR of 6.8% over the forecast period owing to the increasing patient pool and cost-efficient services.
For Requesting a Sample Copy Please Visit @ https://www.grandviewresearch.com/industry-analysis/virtual-clinical-trials-market/request/rs15
Virtual Clinical Trials Market Segmentation
Grand View Research has segmented the global virtual clinical trials market based on study design, indication, and region:
Virtual Clinical Trials Study Design Outlook (Revenue, USD Million, 2017 – 2030)
• Expanded Access
Virtual Clinical Trials Indication Outlook (Revenue, USD Million, 2017 – 2030)
Virtual Clinical Trials Regional Outlook (Revenue, USD Million, 2017 – 2030)
• North America
• The U.S.
• The U.K.
• Asia Pacific
• South Korea
• Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
List of Key Players of Virtual Clinical Trials Market
• ICON, plc
• Parexel International Corporation
• PRA Health Sciences
• LEO Innovation Lab
• CRF Health
• Clinical Ink
• Medable, Inc.
Fill the Pre-Order Enquiry Form for the Report @ https://www.grandviewresearch.com/inquiry/450563/ibb
Browse Related Reports:
Omics-Based Clinical Trials MarketSize, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Region, And Segment Forecasts, 2022 – 2030.
About Grand View Research
Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
Country: United States